Chirality

Ligand-based Virtual Screening

Introduction

The idea of using molecular similarity  to search molecular databases has a long history [1]. Many recent studies have compared shape-matching (ligand-based screening) to docking (ligand-protein screening)  [2, 3, 4].

InhibOx Announces Important Breakthrough in Molecular Similarity: Chiral Shape Recognition (CSR)

Oxford, UK - November 2009

The quantitative measurement of molecular similarity has long been an essential tool in computer-aided drug discovery, in particular for the identification of new leads and scaffold hopping. Until now, however, there has been no fast, non-superpositional method that accounts for enantiomeric (mirror image) molecules, an essential facet of many biological interactions. InhibOx has now made an important breakthrough to meet this challenge.

Syndicate content